HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maya Yamada Selected Research

polaprezinc (Z 103)

1/2015Prevention of radiation esophagitis by polaprezinc (zinc L-carnosine) in patients with non-small cell lung cancer who received chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maya Yamada Research Topics

Disease

3Neoplasms (Cancer)
04/2016 - 03/2013
3Vomiting
04/2016 - 03/2013
3Nausea
04/2016 - 03/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2016 - 01/2015
2Exanthema (Rash)
11/2015 - 03/2013
2Lung Neoplasms (Lung Cancer)
01/2015 - 09/2012
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
11/2015
1Esophagitis
01/2015
1Stomach Ulcer (Gastric Ulcer)
01/2015
1Peripheral Nervous System Diseases (PNS Diseases)
03/2013

Drug/Important Bio-Agent (IBA)

2EmeticsIBA
04/2016 - 01/2016
2AntiemeticsIBA
04/2016 - 09/2012
1Transcription Factors (Transcription Factor)IBA
01/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2016
1AfatinibIBA
07/2016
1Gefitinib (Iressa)FDA Link
07/2016
1AnthracyclinesIBA
04/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2016
1Panitumumab (Vectibix)FDA Link
11/2015
1Monoclonal AntibodiesIBA
11/2015
1Minocycline (Cyclops)FDA LinkGeneric
11/2015
1SteroidsIBA
11/2015
1polaprezinc (Z 103)IBA
01/2015
1AlginatesIBA
01/2015
1SolutionsIBA
01/2015
1drug combination magnesium hydroxide aluminum hydroxide (Maalox)IBA
01/2015
1Granisetron (Kytril)FDA LinkGeneric
09/2012
1azasetronIBA
09/2012
1Carboplatin (JM8)FDA LinkGeneric
09/2012

Therapy/Procedure

4Drug Therapy (Chemotherapy)
04/2016 - 09/2012
3Therapeutics
01/2018 - 01/2015
1Oral Administration
07/2016
1Skin Care
11/2015
1Chemoradiotherapy
01/2015
1Treatment Delay
01/2015